Exhaled nitric oxide in infants--what is a nice test like FENO doing in a place like this?

Esther van Mastrigt1, Carmelo Gabriele, J C de Jongste

  • 1Department of Pediatrics-Respiratory Medicine, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

Fractional exhaled nitric oxide (FENO) measurement shows promise for diagnosing infant conditions like early-onset asthma and primary ciliary dyskinesia. However, standardized methods and reference values are needed for reliable infant FENO testing.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Biomedical Engineering

Background:

  • Fractional exhaled nitric oxide (FENO) is a validated biomarker for eosinophilic airway inflammation in older children and adults.
  • Current FENO measurement techniques are not optimized for infants and preschool-aged children.
  • Wheezing in infants is often transient and linked to viral infections, differing from asthma in older populations.

Purpose of the Study:

  • To review existing data on FENO measurements in infants.
  • To explore the potential clinical utility of FENO in diagnosing and monitoring infant respiratory conditions.
  • To identify challenges and future research needs for infant FENO assessment.

Main Methods:

  • Review of available literature on FENO measurements in infants.
  • Discussion of technical factors influencing FENO levels in infants, including nasal contamination and expiratory flow.
  • Analysis of potential applications of FENO in infant diagnostics.

Main Results:

  • FENO can be measured in infants using tidal breathing or forced passive expiration techniques.
  • Technical challenges such as nasal NO contamination and expiratory flow significantly impact infant FENO readings.
  • Preliminary data suggest FENO may aid in identifying early-onset asthma and primary ciliary dyskinesia (PCD) in infants.

Conclusions:

  • Significant uncertainty remains regarding the clinical utility of FENO in infants.
  • Further research is required to establish standardized methodologies and normal reference values for infant FENO measurements.
  • Clinical studies are needed to demonstrate the specific benefits and limitations of FENO testing in this age group.

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...